Kevin Brough, MD
MOHS-Micrographic Surgery · Wichita, KSNPI 1326484999
Payments from drug & device makers
Across 418 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Amgen$611
- Sun Pharmaceutical Industries Inc.$603
- Lilly USA, LLC$579
- Regeneron Healthcare Solutions, Inc.$411
- plus $2K from 23 others
What the payments were for
- Food & beverage$7,62499%
- Education$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 92 | $1,786 |
| Johnson & Johnson | 89 | $1,543 |
| Amgen | 29 | $611 |
| Sun Pharmaceutical Industries Inc. | 35 | $603 |
| Lilly USA, LLC | 37 | $579 |
| Regeneron Healthcare Solutions, Inc. | 18 | $411 |
| LEO Pharma Inc. | 19 | $356 |
| Sanofi | 12 | $314 |
| UCB, Inc. | 22 | $209 |
| Smith+Nephew | 9 | $150 |
| Incyte Corporation | 7 | $148 |
| Kerecis Limited | 5 | $125 |
| Boehringer Ingelheim | 7 | $122 |
| Mayne Pharma Commercial LLC | 4 | $97 |
| Almirall LLC | 3 | $86 |
| Novartis | 4 | $85 |
| Convatec Inc. | 3 | $76 |
| Organogenesis Inc. | 3 | $55 |
| Organon | 3 | $53 |
| Genentech USA, Inc. | 6 | $52 |
| Fresenius Kabi USA, LLC | 2 | $50 |
| Surgenex LLC | 1 | $33 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $31 |
| Biowound Solutions, Inc. | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $19 |
| Sandoz | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $13 |
How this compares
Too few mohs-micrographic surgery providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 744 | $3,980 |
| Gentamicin Sulfate | 29 | $1,392 |
| Clindamycin Hcl | 164 | $1,133 |
| Mupirocin | 85 | $650 |
| Doxycycline Hyclate | 60 | $539 |
| Oxycodone Hcl | 190 | $382 |
| Ciprofloxacin Hcl | 12 | $76 |
| Amoxicillin | 24 | $40 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Wichita
- Mark FleischmanLeawood$974K
- Joseph GadziaTopeka$257K
- Majdy AlbahharManhattan$10K
- Matthew ShafferSalina$8K
- James GriffithLeawood$5K
- Shawn SabinLeawood$4K
- Glenn GoldsteinLeawood$2K
- Elizabeth SpenceriLeawood$2K
- Jeanette PittsMission$940
- Jesalyn TateKansas City$893
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.